Update on Acquisition of M/s. Naya Pharma Private Limited
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.6 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jeevan Scientific Technology Limited is acquiring a 60% stake (on post-issue paid capital) in M/s. Naya Pharma Private Limited for Rs. 10.00 Crores in cash, to be funded from a preferential issue of 35 lakh convertible warrants and 41.85 lakh equity shares approved at the EGM on November 12, 2025. Naya Pharma, incorporated in August 2020 with a paid-up capital of around Rs. 3.67 Crores, operates in the pharma sector dealing in Active Pharmaceutical Ingredients (APIs), drug intermediates, and chemicals. The deal is a related party transaction, as two of Naya Pharma's shareholders are also promoters of Jeevan Scientific, with common directors on both boards. The acquisition will be completed in tranches and aims to diversify Jeevan's business and create synergy with its existing clinical trials operations.
This move gives Jeevan Scientific a foothold in the pharma sector and could support long-term growth via diversification, but shareholders should note (a) related party involvement, (b) potential dilution from the warrant and equity issuance, and (c) tranche-based execution risk that may delay the full benefit materialising.